Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vira Bitko

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Vaccine|September 14, 2019
Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpesDavid I Bernstein, Rhonda D Cardin, Fernando J Bravo, et al.
Human Vaccines & Immunotherapeutics|December 12, 2013
Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse modelCrystal Passmore, Paul E Makidon, Jessica J O'Konek, et al.
Scientific Reports|July 5, 2022
Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccineYi-Jiun Lin, Meei-Yun Lin, Ya-Shan Chuang, et al.
Plos One|November 2, 2022
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in miceShyamala Ganesan, Hugo Acosta, Chris Brigolin, et al.
Human Vaccines & Immunotherapeutics|August 27, 2015
Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton ratsJessica J O'Konek, Paul E Makidon, Jeffrey J Landers, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Vaccine|September 14, 2019
Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpesDavid I Bernstein, Rhonda D Cardin, Fernando J Bravo, et al.
Human Vaccines & Immunotherapeutics|December 12, 2013
Intranasal immunization with W 80 5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse modelCrystal Passmore, Paul E Makidon, Jessica J O'Konek, et al.
Scientific Reports|July 5, 2022
Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccineYi-Jiun Lin, Meei-Yun Lin, Ya-Shan Chuang, et al.
Plos One|November 2, 2022
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in miceShyamala Ganesan, Hugo Acosta, Chris Brigolin, et al.
Human Vaccines & Immunotherapeutics|August 27, 2015
Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton ratsJessica J O'Konek, Paul E Makidon, Jeffrey J Landers, et al.
Pageof 3